ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
203
5.
Aleu A. Hemorrhagic Complications After Off-Label Thrombolysis for
Ischemic Stroke / Aitziber Aleu, PatricioMellado, Christoph Lichy, Martin
Köhrmann, PeterD. Schellinger // Stroke. – 2007. –38. – p. 417-422.
6.
AlexandrovAV. Clotbust: design of a randomized trial of ultrasound-enhanced
thrombolysis for acute ischemic stroke / AV Alexandrov,AW Wojner, JC
Grotta // J. Neuroimaging. – 2004. –Apr. 14(2). – p. 108-12.
7.
Alexandrov AV. Speed of Intracranial Clot Lysis With Intravenous Tissue
Plasminogen Activator Therapy. Sonographic Classification and Short-Term
Improvement / Andrei V. Alexandrov,W. Scott Burgin, AndrewM. Demchuk,
Ashraf El-Mitwalli // Circulation. –2001. –103. –p. 2897-2902.
8.
Andersen K. Hemorrhagic and Ischemic Strokes Compared Stroke Severity,
Mortality, and Risk Factors / Klaus Kaae Andersen, Tom Skyhøj Olsen,
Christian Dehlendorff, Lars Peter Kammersgaard // Stroke. – 2009. – 40. -
P.2068-2072.
9.
Bhatnagar P. Intravenous thrombolysis in acute ischaemic stroke: a systematic
review and meta-analysis to aid decision making in patients over 80 years of
age / Pallav Bhatnagar , Devesh Sinha, Richard A Parker, Paul Guyler,
AnthonyO'Brien // JNeurol NeurosurgPsychiatry. – 2011. – 82. - P. 712-717/
10.Clark W. Recombinant Tissue-Type Plasminogen Activator (Alteplase) for
Ischemic Stroke 3 to5HoursAfter SymptomOnset. TheATLANTISStudy: A
Randomized Controlled Trial / Wayne M. Clark, Stanley Wissman, Gregory
W. Albers, JackH. Jhamandas, Kenneth P.Madden, Scott Hamilton // JAMA.
– 1999. –282. – p. 2019-2026.
11.ColinD. Global and regional causes of death / D.Mathers Colin, Ties Boerma,
DorisMaFat // BrMedBull. –2009. - 92 (1). –p. 7-32.
12.Derex L. Intracerebral haemorrhage after thrombolysis for acute ischaemic
stroke: an update / L Derex, N Nighoghossian // J Neurol Neurosurg
Psychiatry. – 2008. – 79. – p. 1093-1099.
13.Donnan G. Trials of streptokinase in severe acute ischaemic stroke / Donnan
G., Davis S., ChambersB. et al // Lancet. –1995. – 345. P. 578—579.
14.Edwards N. The Safety of Intravenous Thrombolysis for Ischemic Stroke in
PatientsWith Pre-Existing Cerebral Aneurysms. ACase Series and Review of
the Literature / Nancy J. Edwards, Hooman Kamel , S. Andrew Josephson //
Stroke. – 2012. – 43. – p. 412-416.
15.Fiorelli M. Hemorrhagic transformation within 36 hours of a cerebral infarct:
relationships with early clinical deterioration and 3-month outcome in the
European Cooperative Acute Stroke Study I (ECASS I) cohort / Fiorelli M,
BastianelloS, vonKummerR, et al // Stroke. –1999. -30. –p. 2280–84.
16.Hacke W. Randomised double-blind placebo-controlled trial of thrombolytic
therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) /
Werner Hacke, Markku Kaste, Cesare Fieschi et al // The Lancet. – 1998. -
Volume 352. - Issue 9136. - P. 1245-1251.
